Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Amneal Pharmaceuticals Inc shares valued at $315,766 were sold by BOYER ANDREW S on Aug 15 ’24. At $7.85 per share, BOYER ANDREW S sold 40,225 shares. The insider’s holdings dropped to 256,670 shares worth approximately $2.15 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, BOYER ANDREW S sold 22,486 shares, netting a total of over 175,616 in proceeds. Following the sale of shares at $7.81 each, the insider now holds 296,895 shares.
Before that, Shah Nikita had sold 100,000 shares from its account. In a trade valued at $775,000, the Executive Vice President traded Amneal Pharmaceuticals Inc shares for $7.75 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $2.44 million.
As published in a research note from JP Morgan on September 06, 2024, Amneal Pharmaceuticals Inc [AMRX] has been rated up from an Underweight to a Neutral and the price target has been revised to $9. As of March 08, 2021, Goldman has increased its “Sell” rating to a “Buy” for AMRX. Earlier on December 14, 2020, Guggenheim upgraded its rating. Their new recommendation was “a Buy” for AMRX stock which previously was a “a Neutral”.
Analyzing AMRX Stock Performance
During the last five days, there has been a drop of approximately -1.53%. Over the course of the year, Amneal Pharmaceuticals Inc shares have jumped approximately 37.73%. Shares of the company reached a 52-week high of $8.72 on 08/30/24 and a 52-week low of $5.01 on 03/01/24. A 50-day SMA is recorded $7.66, while a 200-day SMA reached $6.30. Nevertheless, trading volume fell to 0.71 million shares from 0.77 million shares the previous day.
Support And Resistance Levels for Amneal Pharmaceuticals Inc (AMRX)
According to the 24-hour chart, there is a support level at 8.22, which, if violated, would cause prices to drop to 8.07. In the upper region, resistance lies at 8.46. The next price resistance is at 8.55. RSI (Relative Strength Index) is 59.21 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.05, which suggests the price will decrease in the coming days. Percent R is at 52.17%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
